agm feedback, page-5

I would as I think come Jan / Feb 2009 we will get more news on Alimera, another possible lic deal which Paul seemed to alude to and hence some more cash in the door.

Plus in Jan Pfizer R&D kicks in.

I think you need to remember this :

Ashton is the largest shareholder and has the most to gain from a higher SP and the SP was actually steady @ 12 - 14 cents for some time until a large number of shares were dumped onto the market about 3 - 4 weeks ago which sent us down to 10 cents.

I continue to hold a large position and will continue to top up as the SP remains this low.

I really think Management do not want to raise money via selling shares and hence you will have to see something give on a lic deal with some upfront cash.

I also understand company is doing a roadshow in Europe and US in early December so now may be the best (cheapest) time to buy and given 70 mil market cap it is one of the cheapest Bio-techs on the market !